SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008638
Filing Date
2018-11-06
Accepted
2018-11-06 16:17:41
Documents
74
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q idra-20180930x10q.htm 10-Q 1604198
2 EX-10.1 idra-20180930ex101b98c05.htm EX-10.1 27183
3 EX-31.1 idra-20180930ex3114eec38.htm EX-31.1 18377
4 EX-31.2 idra-20180930ex3127d99a5.htm EX-31.2 18886
5 EX-32.1 idra-20180930ex32162d35a.htm EX-32.1 7944
6 EX-32.2 idra-20180930ex322cfe30b.htm EX-32.2 8351
7 GRAPHIC idra20180930ex101b98c05001.jpg GRAPHIC 154871
8 GRAPHIC idra20180930x10q001.jpg GRAPHIC 14972
9 GRAPHIC idra20180930x10q002.jpg GRAPHIC 3116
10 GRAPHIC idra20180930x10q003.jpg GRAPHIC 8010
11 GRAPHIC idra20180930x10q004.jpg GRAPHIC 7572
12 GRAPHIC idra20180930x10q005.jpg GRAPHIC 4183
13 GRAPHIC idra20180930x10q006.jpg GRAPHIC 7470
  Complete submission text file 0001558370-18-008638.txt   6456452

Data Files

Seq Description Document Type Size
14 EX-101.INS idra-20180930.xml EX-101.INS 1395219
15 EX-101.SCH idra-20180930.xsd EX-101.SCH 45369
16 EX-101.CAL idra-20180930_cal.xml EX-101.CAL 38319
17 EX-101.DEF idra-20180930_def.xml EX-101.DEF 148748
18 EX-101.LAB idra-20180930_lab.xml EX-101.LAB 335235
19 EX-101.PRE idra-20180930_pre.xml EX-101.PRE 285808
Mailing Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341
Business Address 505 EAGLEVIEW BOULEVARD SUITE 212 EXTON PA 19341 4843481600
IDERA PHARMACEUTICALS, INC. (Filer) CIK: 0000861838 (see all company filings)

IRS No.: 043072298 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-31918 | Film No.: 181163216
SIC: 2836 Biological Products, (No Diagnostic Substances)
Assistant Director 1